Janux Therapeutics announced the close of a $56 million Series A financing led by Avalon Ventures and joined by new investors, OrbiMed and RA Capital…
Biotechnology company Artizan Biosciences announced the closing of an $11 million Series A-2 financing round, led by existing investors Hatteras Venture Partners, Elm Street Ventures…
Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all…
With enormous sums of capital managed in the UK, its managers seek optimal scientific-based investments to not only progress health and medicine but also generate…
Thanks to an $3.75 million grant injection from the Cancer Institute, NSW Translational Program, researchers and clinicians from UNSW and the Garvan Institute in Australia…
Moderna Inc. (Nasdaq: MRNA), the biotechnology company with one of the authorized vaccines for COVID-19, completed the manufacturing of clinical trial material for its variant-specific…
Individuals from SoftBank Group Corp frequent the TrialSite News website on a daily basis. Clearly, there are individuals interested in the particular site and transparency perspective…
The contract research organization (CRO), critically important in the world of drug development and clinical trials, represents a near $64 billion industry within just a…
Axis Spine Technologies Ltd (AST) has raised £2.2m in a funding round led by ACF Investors, with follow-on investment from Mercia’s EIS funds. Mercia was the first…
Centessa Pharmaceuticals (“Centessa”) launched today as a novel asset-centric pharmaceutical company designed and built to advance a portfolio of highly validated programs. Centessa’s asset-centric R&D…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
